Format

Send to

Choose Destination
Gac Med Mex. 2009 Jan-Feb;145(1):41-9.

[Treatment guidelines for ankylosing spondylitis and its effect on Mexican rheumatology].

[Article in Spanish]

Author information

1
Servicio de Reumatología, Hospital General de México, Dr. Balmis 148, Col. Doctores, Del. Cuauhtémoc, 06720 México D.F., México. burgosv@prodigy.net.mx

Abstract

We describe the guidelines for the current treatment of ankylosing spondylitis with an emphasis on the role and outlook of the Mexican rheumatologic community. The topics we analyze include: epidemiological as well as professional, financial, health status, and quality of life aspects. We propose to acknowledge that axial spondyloarthritis is the earliest form of ankylosing spondylitis. Finally we carry out a review of the literature supporting current therapeutic recommendations. Regarding the latter, we approached the ASAS/EULAR recommendations for the treatment of ankylosing spondylitis and their level of agreement with Mexican and other countries' rheumatologists. Finally, we analyzed the recommendations to start tumor necrosis alpha blockers among patients with ankylosing spondylitis.

PMID:
19256410
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center